XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.33%14.35B | 6.96%27.6B | 12.98%14.02B | 14.31%25.8B | 21.69%12.41B | 56.13%22.57B | 64.97%10.2B | 4.23%14.46B | -1.18%6.18B | 31.95%13.87B |
Operating income | 2.33%14.35B | 6.96%27.6B | 12.98%14.02B | 14.31%25.8B | 21.69%12.41B | 56.13%22.57B | 64.97%10.2B | 4.23%14.46B | -1.18%6.18B | 31.95%13.87B |
Cost of sales | 0.98%-7.11B | -6.97%-14.25B | -15.66%-7.18B | -25.61%-13.32B | -38.03%-6.21B | -44.01%-10.6B | -43.96%-4.5B | -4.22%-7.36B | 0.72%-3.12B | -29.42%-7.06B |
Operating expenses | 0.98%-7.11B | -6.97%-14.25B | -15.66%-7.18B | -25.61%-13.32B | -38.03%-6.21B | -44.01%-10.6B | -43.96%-4.5B | -4.22%-7.36B | 0.72%-3.12B | -29.42%-7.06B |
Gross profit | 5.80%7.24B | 6.95%13.35B | 10.29%6.84B | 4.31%12.48B | 8.80%6.2B | 68.71%11.97B | 86.44%5.7B | 4.24%7.09B | -1.65%3.06B | 34.69%6.81B |
Selling expenses | -9.59%-4.33B | -24.14%-9.08B | -16.71%-3.95B | -19.16%-7.31B | -18.41%-3.38B | -38.72%-6.14B | -46.61%-2.86B | 0.46%-4.42B | 3.69%-1.95B | -19.86%-4.45B |
Administrative expenses | -15.16%-680.3M | -12.84%-1.26B | -14.02%-590.76M | -0.23%-1.11B | -18.43%-518.1M | -37.96%-1.11B | -26.33%-437.46M | 16.86%-805.06M | 23.21%-346.28M | -42.42%-968.26M |
Impairment and provision | -195.02%-10.27M | -19.25%19.64M | 47.20%10.81M | 55.09%24.32M | 210.86%7.34M | 151.47%15.68M | 72.88%-6.62M | -348.54%-30.47M | -23,808.74%-24.42M | -32.56%12.26M |
-Other impairment is provision | -195.02%-10.27M | -19.25%19.64M | 47.20%10.81M | 55.09%24.32M | 210.86%7.34M | 151.47%15.68M | 72.88%-6.62M | -348.54%-30.47M | -23,808.74%-24.42M | -32.56%12.26M |
Special items of operating profit | 11.47%183.74M | -34.96%523.67M | -51.03%164.83M | 101.12%805.17M | 139.66%336.6M | 10.63%400.35M | -12.49%140.45M | 160.67%361.87M | 262.26%160.5M | 46.83%138.82M |
Operating profit | -2.96%2.4B | -27.17%3.56B | -6.37%2.48B | -4.86%4.89B | 4.14%2.64B | 133.90%5.14B | 182.70%2.54B | 42.30%2.2B | 32.42%897.91M | 98.57%1.54B |
Financing income | -27.48%221.24M | 11.79%500.56M | 33.45%305.07M | 208.59%447.75M | 403.67%228.61M | 318.65%145.1M | 134.03%45.39M | 20.04%34.66M | 6.55%19.39M | 23.52%28.87M |
Financing cost | -48.54%-120.86M | -50.50%-181.45M | -48.27%-81.37M | -7.21%-120.56M | -44.70%-54.88M | -69.75%-112.46M | -18.93%-37.93M | -12.28%-66.25M | -20.60%-31.89M | -325.57%-59.01M |
Special items of earning before tax | 8.82%110.86M | 87.90%377.97M | 0.22%101.87M | 26.34%201.16M | 27.74%101.65M | 90.71%159.22M | 265.56%79.57M | -75.69%83.49M | -92.99%21.77M | 439.77%343.47M |
Earning before tax | -6.70%2.61B | -21.40%4.26B | -4.05%2.8B | 1.63%5.42B | 11.18%2.92B | 137.04%5.33B | 189.41%2.63B | 21.08%2.25B | -7.46%907.18M | 118.33%1.86B |
Tax | 2.71%-661.1M | 20.88%-1.07B | 6.88%-679.52M | -2.58%-1.35B | -10.02%-729.69M | -139.79%-1.32B | -196.20%-663.22M | -53.71%-549.38M | -20.83%-223.91M | -164.63%-357.4M |
After-tax profit from continuing operations | -7.98%1.95B | -21.58%3.19B | -3.11%2.12B | 1.32%4.06B | 11.57%2.19B | 136.15%4.01B | 187.18%1.96B | 13.30%1.7B | -14.05%683.27M | 109.59%1.5B |
Earning after tax | -7.98%1.95B | -21.58%3.19B | -3.11%2.12B | 1.32%4.06B | 11.57%2.19B | 136.15%4.01B | 187.18%1.96B | 13.30%1.7B | -14.05%683.27M | 109.59%1.5B |
Minority profit | ---- | 182.54%52K | --52K | -1,000.00%-63K | ---- | --7K | ---- | ---- | ---- | --4K |
Profit attributable to shareholders | -7.98%1.95B | -21.58%3.19B | -3.11%2.12B | 1.32%4.06B | 11.57%2.19B | 136.14%4.01B | 187.18%1.96B | 13.30%1.7B | -14.05%683.27M | 109.59%1.5B |
Basic earnings per share | -5.99%0.758 | -20.70%1.2321 | -3.75%0.8063 | -2.95%1.5538 | 5.98%0.8377 | 131.32%1.601 | 182.49%0.7904 | 11.74%0.6921 | -14.90%0.2798 | 109.04%0.6194 |
Diluted earnings per share | -6.04%0.7549 | -20.53%1.2266 | -3.20%0.8034 | -2.30%1.5434 | 6.46%0.83 | 133.61%1.5797 | 185.57%0.7796 | 12.46%0.6762 | -14.90%0.273 | 106.00%0.6013 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.